
Biocryst Pharmaceuticals Inc (BCRX) is destined for greater heights as its last quarter sales were 145,530 K
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Monday, plunged -3.11% from the previous trading day, before settling in for the closing price of $9.66. Within the